Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Repeated annual influenza vaccination and vaccine effectiveness: review of evidenceExpert review of vaccines, 2017-07, Vol.16 (7), p.723-736 [Peer Reviewed Journal]2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2017 ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2017.1334554 ;PMID: 28562111Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysisExpert review of vaccines, 2018-05, Vol.17 (5), p.435-443 [Peer Reviewed Journal]ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2018.1471989 ;PMID: 29715054Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
The impact of maternal- and neonatal-associated factors on human milk's macronutrients and energyThe journal of maternal-fetal & neonatal medicine, 2017-06, Vol.30 (11), p.1302-1308 [Peer Reviewed Journal]2016 Informa UK Limited, trading as Taylor & Francis Group. 2016 ;ISSN: 1476-7058 ;EISSN: 1476-4954 ;DOI: 10.1080/14767058.2016.1212329 ;PMID: 27405688Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected CellsInternational journal of nanomedicine, 2019-01, Vol.14, p.8755-8768 [Peer Reviewed Journal]2019 Ferrantelli et al. ;2019 Ferrantelli et al. 2019 Ferrantelli et al. ;ISSN: 1178-2013 ;ISSN: 1176-9114 ;EISSN: 1178-2013 ;DOI: 10.2147/IJN.S209366 ;PMID: 31806970Full text available |
|
5 |
Material Type: Article
|
Management of high-risk HPV-positive women for detection of cervical (pre)cancerExpert review of molecular diagnostics, 2016-09, Vol.16 (9), p.961-974 [Peer Reviewed Journal]2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2016 ;ISSN: 1473-7159 ;EISSN: 1744-8352 ;DOI: 10.1080/14737159.2016.1217157 ;PMID: 27459506Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
More than sugar in the milk: human milk oligosaccharides as essential bioactive molecules in breast milk and current insight in beneficial effectsCritical reviews in food science and nutrition, 2021, Vol.61 (7), p.1184-1200 [Peer Reviewed Journal]2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 ;2020 The Author(s). Published with license by Taylor & Francis Group, LLC. This work is licensed under the Creative Commons Attribution – Non-Commercial – No Derivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1040-8398 ;EISSN: 1549-7852 ;DOI: 10.1080/10408398.2020.1754756 ;PMID: 32329623Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Bacillus cereus contamination of pasteurized human milk donations: frequency, origin, seasonal distribution, molecular typing of strains and proposed corrective/preventive actionsThe journal of maternal-fetal & neonatal medicine, 2022-04, Vol.35 (8), p.1554-1561 [Peer Reviewed Journal]2020 Informa UK Limited, trading as Taylor & Francis Group 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1476-7058 ;EISSN: 1476-4954 ;DOI: 10.1080/14767058.2020.1763295 ;PMID: 32393084Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Head‐to‐head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cellsJournal of extracellular vesicles, 2024-05, Vol.13 (5), p.e12445-n/a [Peer Reviewed Journal]2024 AstraZeneca R&D and The Authors. published by Wiley Periodicals LLC on behalf of International Society for Extracellular Vesicles. ;2024 AstraZeneca R&D and The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals LLC on behalf of International Society for Extracellular Vesicles. ;Attribution ;ISSN: 2001-3078 ;EISSN: 2001-3078 ;DOI: 10.1002/jev2.12445 ;PMID: 38711334Full text available |
|
9 |
Material Type: Article
|
The history of MF59® adjuvant: a phoenix that arose from the ashesExpert review of vaccines, 2013-01, Vol.12 (1), p.13-30 [Peer Reviewed Journal]2013 Expert Reviews Ltd 2013 ;2014 INIST-CNRS ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.12.140 ;PMID: 23256736Full text available |
|
10 |
Material Type: Article
|
Genomic analysis of a large set of currently-and historically-important human adenovirus pathogensEmerging microbes & infections, 2018-02, Vol.7 (1), p.1-22 [Peer Reviewed Journal]The Author(s) 2018 2018 ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018, corrected publication 2018 ;ISSN: 2222-1751 ;EISSN: 2222-1751 ;DOI: 10.1038/s41426-017-0004-y ;PMID: 29410402Full text available |
|
11 |
Material Type: Article
|
Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian populationExpert review of vaccines, 2023-12, Vol.22 (1), p.608-619 [Peer Reviewed Journal]2023 CSL Seqirus Ltd. Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2023.2229917 ;PMID: 37368472Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Universal influenza vaccines: from viruses to nanoparticlesExpert review of vaccines, 2018-11, Vol.17 (11), p.967-976 [Peer Reviewed Journal]2018 Informa UK Limited, trading as Taylor & Francis Group 2018 ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2018.1541408 ;PMID: 30365905Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasonsExpert review of vaccines, 2024, Vol.23 (1), p.124-136 [Peer Reviewed Journal]ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2023.2293237 ;PMID: 38073493Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
The evolving history of influenza viruses and influenza vaccinesExpert review of vaccines, 2013-09, Vol.12 (9), p.1085-1094 [Peer Reviewed Journal]Informa UK, Ltd. 2013 ;2014 INIST-CNRS ;COPYRIGHT 2013 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/14760584.2013.824709 ;PMID: 24024871Full text available |
|
15 |
Material Type: Article
|
The burden of seasonal influenza: improving vaccination coverage to mitigate morbidity and its impact on healthcare systemsExpert review of vaccines, 2023-12, Vol.22 (1), p.518-519 [Peer Reviewed Journal]2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2023.2221345 ;PMID: 37264896Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Influenza vaccine failure: failure to protect or failure to understand?Expert review of vaccines, 2018-06, Vol.17 (6), p.495-502 [Peer Reviewed Journal]2018 Informa UK Limited, trading as Taylor & Francis Group 2018 ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2018.1484284 ;PMID: 29883218Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysisExpert review of vaccines, 2019-03, Vol.18 (3), p.295-308 [Peer Reviewed Journal]2019 Informa UK Limited, trading as Taylor & Francis Group 2019 ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2019.1575734 ;PMID: 30689467Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Antibodies in the breast milk of a maternal woman with COVID-19Emerging microbes & infections, 2020-01, Vol.9 (1), p.1467-1469 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 The Author(s) ;ISSN: 2222-1751 ;EISSN: 2222-1751 ;DOI: 10.1080/22221751.2020.1780952 ;PMID: 32552365Full text available |
|
19 |
Material Type: Article
|
Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitorsJournal of enzyme inhibition and medicinal chemistry, 2017-01, Vol.32 (1), p.403-425 [Peer Reviewed Journal]2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2017 ;2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/Licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2017 The Author(s). ;ISSN: 1475-6366 ;EISSN: 1475-6374 ;DOI: 10.1080/14756366.2016.1256882 ;PMID: 28097901Full text available |
|
20 |
Material Type: Article
|
Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the USExpert review of vaccines, 2024-12, Vol.23 (1), p.82-87 [Peer Reviewed Journal]ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1080/14760584.2023.2295014 ;PMID: 38093415Digital Resources/Online E-Resources |